A retrospective chart review compared the difference in outcomes between Black patients and White patients with advanced RCC for 3 first-line therapies.

The objective response rate was 78.6% in the overall cohort, 76.9% in patients with a PD-L1 combined positive score (CPS) below 1, 68.8% in patients with a PD-L1 CPS of 1-9, and 100% in patients with ...

Study results “provide strong support for integrating symptom screening and care pathways into routine clinical care,” according to researchers ...

Greatest increases in early-onset colorectal cancer incidence rates seen in New Zealand, Chile, Puerto Rico, and England.

Researchers sought to determine if HRQoL measures differ with gilteritinib compared with placebo in patients with AML.

Researchers investigated the prevalence of psychiatric disorders and need for psycho-oncology support among patients with breast cancer.

Though lung cancer survival rates are improving, lung cancer is still the leading cause of cancer deaths in the US.

Researchers found that a cancer diagnosis was associated with greater financial debt, credit card debt, and use of previously accumulated home equity.

Researchers evaluated vitreoretinal lymphoma and concomitant central nervous system lymphoma testing modalities.

Researchers found no significant differences in response or survival outcomes between patients with dMMR and pMMR endometrial cancer.

Adding olaparib to bevacizumab was safe with good quality of life in older patients with advanced ovarian cancer.

Researchers concluded that dabrafenib and trametinib appeared active in the second-line adjuvant setting, “although more follow up is required to confirm.” ...